Literature DB >> 22707191

Highly cytotoxic trithiophenolatodiruthenium complexes of the type [(η6-p-MeC6H4Pri)2Ru2(SC6H4-p-X)3]+: synthesis, molecular structure, electrochemistry, cytotoxicity, and glutathione oxidation potential.

Federico Giannini1, Julien Furrer, Anne-Flore Ibao, Georg Süss-Fink, Bruno Therrien, Olivier Zava, Mathurin Baquie, Paul J Dyson, Petr Stěpnička.   

Abstract

A series of cationic dinuclear p-cymene ruthenium trithiophenolato complexes of the type [(η(6)-p-MeC(6)H(4)Pr(i))(2)Ru(2)(SC(6)H(4)-p-X)(3)](+) (1 X is H, 2 X is Me, 3 X is Ph, 4 X is Br, 5 X is OH, 6 X is NO(2), 7 X is OMe, 8 X is CF(3), 9 X is F, 10 X is Pr(i), 11 X is Bu(t)) have been synthesized from the reaction of [(η(6)-p-MeC(6)H(4)Pr(i))RuCl(2)](2) with the corresponding thiol, isolated as the chloride salts, and further studied for their electrochemical properties, cytotoxicity towards human ovarian cancer cells, and catalytic activity for glutathione (GSH) oxidation. Complex 1 was also compared with the benzene and hexamethylbenzene analogues [(η(6)-C(6)H(6))(2)Ru(2)(SC(6)H(5))(3)](+) (12) and [(η(6)-C(6)Me(6))(2)Ru(2)(SC(6)H(5))(3)](+) (13). The most active compound [11]Cl was structurally studied by single-crystal X-ray diffraction analysis. The concentrations corresponding to 50 % inhibition of cancer cell growth (IC(50) values) in the A2780 and A2780cisR cell lines of these complexes except for 6 were in the submicromolar range, complex 11 showing an IC(50) value of 0.03 µM in both cell lines. The high in vitro anticancer activity of these complexes may be at least partially due to their catalytic potential for the oxidation of GSH, although there is no clear correlation between the IC(50) values and the turnover frequencies at about 50 % conversion. However, the cytotoxicity is tentatively correlated to the physicochemical properties of the compounds determined by the electronic influence of the substituents X (Hammett constants σ(p)) and the lipophilicity of the thiols p-XC(6)H(4)SH (calculated log P parameters).

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22707191     DOI: 10.1007/s00775-012-0911-2

Source DB:  PubMed          Journal:  J Biol Inorg Chem        ISSN: 0949-8257            Impact factor:   3.358


  24 in total

1.  Library of second-generation cycloruthenated compounds and evaluation of their biological properties as potential anticancer drugs: passing the nanomolar barrier.

Authors:  Ludivine Fetzer; Bastien Boff; Moussa Ali; Meng Xiangjun; Jean-Paul Collin; Claude Sirlin; Christian Gaiddon; Michel Pfeffer
Journal:  Dalton Trans       Date:  2011-08-12       Impact factor: 4.390

2.  Synthesis of betulin derivatives and the determination of their relative lipophilicities using reversed-phase thin-layer chromatography.

Authors:  Jacek Achrem-Achremowicz; Elzbieta Kepczyńska; Marek Zylewski; Zbigniew Janeczko
Journal:  Biomed Chromatogr       Date:  2010-03       Impact factor: 1.902

3.  Efficient oxidation of cysteine and glutathione catalyzed by a dinuclear areneruthenium trithiolato anticancer complex.

Authors:  Federico Giannini; Georg Süss-Fink; Julien Furrer
Journal:  Inorg Chem       Date:  2011-10-07       Impact factor: 5.165

4.  Tuning the hydrophobicity of ruthenium(II)-arene (RAPTA) drugs to modify uptake, biomolecular interactions and efficacy.

Authors:  Claudine Scolaro; Adrian B Chaplin; Christian G Hartinger; Alberta Bergamo; Moreno Cocchietto; Bernhard K Keppler; Gianni Sava; Paul J Dyson
Journal:  Dalton Trans       Date:  2007-09-26       Impact factor: 4.390

5.  Inhibition of cancer cell growth by ruthenium(II) arene complexes.

Authors:  R E Morris; R E Aird; P del S Murdoch; H Chen; J Cummings; N D Hughes; S Parsons; A Parkin; G Boyd; D I Jodrell; P J Sadler
Journal:  J Med Chem       Date:  2001-10-25       Impact factor: 7.446

6.  Induced-fit recognition of DNA by organometallic complexes with dynamic stereogenic centers.

Authors:  Haimei Chen; John A Parkinson; Olga Nováková; Juraj Bella; Fuyi Wang; Alice Dawson; Robert Gould; Simon Parsons; Viktor Brabec; Peter J Sadler
Journal:  Proc Natl Acad Sci U S A       Date:  2003-12-01       Impact factor: 11.205

7.  The hydrolysis of the anti-cancer ruthenium complex NAMI-A affects its DNA binding and antimetastatic activity: an NMR evaluation.

Authors:  Marina Bacac; Anna C G Hotze; Karlijn van der Schilden; Jaap G Haasnoot; Sabrina Pacor; Enzo Alessio; Gianni Sava; Jan Reedijk
Journal:  J Inorg Biochem       Date:  2004-02       Impact factor: 4.155

8.  Kinetics of aquation and anation of ruthenium(II) arene anticancer complexes, acidity and X-ray structures of aqua adducts.

Authors:  Fuyi Wang; Haimei Chen; Simon Parsons; Iain D H Oswald; James E Davidson; Peter J Sadler
Journal:  Chemistry       Date:  2003-12-05       Impact factor: 5.236

9.  Catalytic organometallic anticancer complexes.

Authors:  Sarah J Dougan; Abraha Habtemariam; Sarah E McHale; Simon Parsons; Peter J Sadler
Journal:  Proc Natl Acad Sci U S A       Date:  2008-08-07       Impact factor: 11.205

10.  Highly selective binding of organometallic ruthenium ethylenediamine complexes to nucleic acids: novel recognition mechanisms.

Authors:  Haimei Chen; John A Parkinson; Robert E Morris; Peter J Sadler
Journal:  J Am Chem Soc       Date:  2003-01-08       Impact factor: 15.419

View more
  6 in total

1.  Characterization of the Activities of Dinuclear Thiolato-Bridged Arene Ruthenium Complexes against Toxoplasma gondii.

Authors:  Afonso P Basto; Joachim Müller; Riccardo Rubbiani; David Stibal; Federico Giannini; Georg Süss-Fink; Vreni Balmer; Andrew Hemphill; Gilles Gasser; Julien Furrer
Journal:  Antimicrob Agents Chemother       Date:  2017-08-24       Impact factor: 5.191

2.  Chlorambucil conjugates of dinuclear p-cymene ruthenium trithiolato complexes: synthesis, characterization and cytotoxicity study in vitro and in vivo.

Authors:  David Stíbal; Bruno Therrien; Georg Süss-Fink; Patrycja Nowak-Sliwinska; Paul J Dyson; Eva Čermáková; Martina Řezáčová; Pavel Tomšík
Journal:  J Biol Inorg Chem       Date:  2016-04-04       Impact factor: 3.358

3.  Dinuclear thiolato-bridged arene ruthenium complexes: from reaction conditions and mechanism to synthesis of new complexes.

Authors:  Hedvika Primasová; Silviya Ninova; Mario de Capitani; Jana Daepp; Ulrich Aschauer; Julien Furrer
Journal:  RSC Adv       Date:  2020-11-04       Impact factor: 4.036

4.  Coumarin-Tagged Dinuclear Trithiolato-Bridged Ruthenium(II)⋅Arene Complexes: Photophysical Properties and Antiparasitic Activity.

Authors:  Oksana Desiatkina; Emilia Păunescu; Martin Mösching; Nicoleta Anghel; Ghalia Boubaker; Yosra Amdouni; Andrew Hemphill; Julien Furrer
Journal:  Chembiochem       Date:  2020-06-16       Impact factor: 3.164

5.  Crystal structure of (μ-4-hy-droxy-benzene-thiol-ato-κ(2) S:S)bis-(μ-phenyl-methane-thiol-ato-κ(2) S:S)bis-[(η(6)-1-isopropyl-4-methyl-benzene)-ruthenium(II)] tetra-fluorido-borate.

Authors:  David Stíbal; Georg Süss-Fink; Bruno Therrien
Journal:  Acta Crystallogr E Crystallogr Commun       Date:  2015-09-12

6.  Crystal structure of bis-[μ-(4-meth-oxy-phen-yl)methane-thiol-ato-κ(2) S:S]bis-[chlorido-(η(6)-1-isopropyl-4-methyl-benzene)-ruthenium(II)] chloro-form disolvate.

Authors:  David Stíbal; Georg Süss-Fink; Bruno Therrien
Journal:  Acta Crystallogr E Crystallogr Commun       Date:  2015-09-26
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.